Navigation Links
Amarin Announces Financial Results for Fourth Quarter and Full Year 2007
Date:5/19/2008

DUBLIN, Ireland, May 19 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN) ("Amarin" or "Company") today reported financial results for the fourth quarter and full year ended December 31, 2007. For the fourth quarter of 2007, Amarin reported a net loss of $7.9 million, or $0.72 per share, compared with a net loss of $5.0 million, or $0.57 per share, in the fourth quarter of 2006. The increase in net loss for the quarter is primarily due to reorganization costs and higher share-based compensation costs.

For the year ended December 31, 2007, Amarin reported a net loss of $38.2 million or $3.90 per share, compared with a net loss of $26.8 million or $3.25 per share for the year ended December 31, 2006. The increase in net loss for the year is primarily due to the previously announced write-off of the Miraxion intangible asset of $8.8 million in the second quarter of 2007, reorganization costs and higher share-based compensation costs, partly offset by a reduction in research and development costs.

The net loss per share amounts reflect the one-for-ten reverse stock split which took effect on January 18, 2008. Figures for the comparative periods have been restated to International Financial Reporting Standards ("IFRS"). For further information with respect to the application of IFRS to our accounts, please refer to our 2007 IFRS Annual Report on Form 20-F filed with the United States Securities and Exchange Commission ("SEC") on May 19, 2008 and our IFRS transition document which was furnished to the SEC on Form 6-K and is available on the Company's website.

Three months ended December 31, 2007

For the quarter ended December 31, 2007, Amarin's operating loss was $7.7 million, compared with an operating
'/>"/>

SOURCE Amarin Corporation Plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Amarin Secures Global Intellectual Property Rights for Lipid Programs
2. Amarin Appoints Dr. William Mason as Lead Independent Director
3. Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
4. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
5. Amarin Signs Agreement to Acquire Ester Neurosciences
6. Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference
7. Amarin Announces Initiation of Cardiovascular Development Strategy
8. Amarin to Present at 4th Annual Bio Investor Forum
9. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
10. Volcano Announces Acquisition of Novelis, Inc.
11. RainDance Announces Company Relocation and Manufacturing Startup
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Esperance Pharmaceuticals Inc. today reported positive results ... in ovarian cancer patients resistant to paclitaxel. EP-100 is ... cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors ... wide range of cancers. Results of ... were presented at the 2015 ASCO Annual Meeting ...
(Date:6/1/2015)... June 1, 2015  Berg, a biopharmaceutical company committed ... presented clinical research from its trials using its cancer ... preclinical data on triple negative breast cancer, at the ... of Clinical Oncology (ASCO), May 29 – June 2 ... BPM 31510 is one of the first cancer drugs ...
(Date:6/1/2015)... , June 1, 2015  Albany ... announced today that it has signed a ... to co-market their structure-based drug discovery services ... part of the three-year agreement, AMRI gains ... expertise and capabilities. HarkerBIO,s customers will be ...
(Date:6/1/2015)... 29, 2015 Research and Markets( ... the "2015 Strategies in the US ... their offering. This new 373-page ... comprehensive analysis of the POC clinical chemistry ... requirements, technological trends, competitive landscape, and emerging ...
Breaking Biology Technology:Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 2Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 3AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 2AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 3
... Alternative will be Centerpiece to Expansion of ... Radiation Oncology ... ARAY ), a global leader in the field of radiosurgery,today ... CyberKnife(R) Robotic Radiosurgery System to further expand treatment,offerings for its ...
... Corn Borer Technology Offers Greater Control of Common, ... Southern U.S. Growers, ST. LOUIS, July 24 ... deregulated MON 89034, a new insect,protection technology from ... above ground insect control technology will be stacked ...
... United,Therapeutics Corporation (Nasdaq: UTHR ) announced ... financial results before the open of market,on Thursday, ... a half-hour teleconference on Thursday,July 31, 2008, at ... dialing 1-800-603-1777, with international callers dialing,1-706-679-8129. A rebroadcast ...
Cached Biology Technology:St. Luke's Episcopal Hospital to Add CyberKnife System to Treatment Offerings 2St. Luke's Episcopal Hospital to Add CyberKnife System to Treatment Offerings 3St. Luke's Episcopal Hospital to Add CyberKnife System to Treatment Offerings 4New Insect Protection Technology From Monsanto Company Deregulated by USDA 2New Insect Protection Technology From Monsanto Company Deregulated by USDA 3
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... 11, 2015  Through a well-rounded UAS delegation representing private ... a strong showing at AUVSI,s Unmanned 2015 conference last week ... Ohio,s UAS industry met with over 200 ... points along the UAS ecosystem. "Our message ... President for Aerospace Rich Knoll . "If you want ...
(Date:5/10/2015)... 2015 Fingerprint Cards (FPC) has received ... from the distributor World Peace Industrial Group (WPI), part of ... Asia . Deliveries are planned to take place ... smartphone manufacturers in China . The order ... guidance of + 1 000 MSEK for 2015.   ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
... remains a goal for governments around the world, nuclear ... as recognised at the 2010 nuclear security summit in ... prevent the proliferation of nuclear weapons, but they are ... role science in this field. A new European nuclear ...
... Researchers from the Georgia Institute of Technology have ... of people worldwide from dying of pneumonia each year. ... is a solution to the problem of diagnosing pneumonia, ... for Disease Control and Prevention (CDC). Pneumonia, an ...
... University of Arizona College of Engineering researcher and his ... will be featured in a segment of an upcoming ... will be featured on the episode premiering Thursday night, ... KUAT Channel 6. "WaveLengths" is a quarterly science program ...
Cached Biology News:Enhancing nuclear security: Training and international collaboration 2A better way to diagnose pneumonia 2A better way to diagnose pneumonia 3Planetary exploration robots to be featured on science program 'WaveLengths' 2
... Ion Channel Cell Lines ,High Quality, Functionally-Validated, ... are well known for having a critical ... consequently have a key function in pain, ... ion channels have been investigated in therapeutic ...
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
... Protein Staining Solution stains proteins ... electrophoresis (detection limit >= 8 ng ... including washing and destaining processes can ... staining of gel (20 min), proteins ...
Mouse monoclonal antibody raised against a partial recombinant PASK. NCBI Entrez Gene ID = PASK...
Biology Products: